×
Suggest this Article to:
TOP INDEXERS
Public Article
-
verified
Development of Acute Generalized Exanthematous Pustulosis due to Hydroxychloroquine Use for COVID-19 Treatment
ISSN: 2687 - 5365
Publisher: author
Development of Acute Generalized Exanthematous Pustulosis due to Hydroxychloroquine Use for COVID-19 Treatment
Indexed in
Medical Sciences
ARTICLE-FACTOR
1.3
Article Basics Score: 3
Article Transparency Score: 3
Article Operation Score: 2
Article Articles Score: 2
Article Accessibility Score: 3
SUBMIT PAPER ASK QUESTION
International Category Code (ICC):
ICC-1702
Publisher: International Journal Of Academic Medicine And Pharmacy Ne..
International Journal Address (IAA):
IAA.ZONE/268782055365
eISSN
:
2687 - 5365
VALID
ISSN Validator
Abstract
Acute generalized exanthematous pustulosis (AGEP) is a cutaneous drug eruption, which is characterized by nonfollicular, sterile pustules, rapidly and severely progresses on an erythematous base. Although antibiotics have been considered to be responsible for most of the development of AGEP, many drugs, such as hydroxychloroquine (HCQ), may also cause it. Recently, HCQ is frequently used in the prophylaxis and treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection along with antiviral drugs. In our study, we have presented an AGEP reaction case that has been developed in one patient who is being treated for coronavirus disease-19 (COVID-19) and using the HCQ.
